The Two-Step TB Test: What It Is, Who Needs It, the Schedule, and the One-Visit Alternative

The tuberculin skin test (TST, also called PPD or Mantoux) tests for TB infection by injecting a small amount of tuberculin under the skin of the forearm and measuring the firm bump (induration) that forms 48 to 72 hours later. A two-step test is simply that procedure done twice: if the first test is negative, a second is placed one to three weeks later and read the same way. The result of the second test is recorded as your baseline.

It is used for one purpose — establishing a reliable starting point for people who will be tested again in the future. It is not a more sensitive test, and it is not used to work up symptoms. Someone who needs a single TB test for a school form or a one-time job requirement almost never needs the two-step version.

In a person infected with TB bacteria many years ago — or vaccinated with BCG in childhood — the immune memory the skin test relies on can fade to the point where a first test reads negative. The act of placing that first test can wake the memory back up, so a test given a few weeks or months later reads positive. That delayed positive is called boosting, and on its own it looks exactly like a new infection.

For a hospital or nursing program that retests staff and students, that ambiguity is expensive: a "conversion" on an annual test triggers a chest X-ray, an evaluation, sometimes treatment, and a search for where the exposure happened. The two-step baseline removes it. If the second test reads positive, that reaction is recorded as an old, boosted response — your true baseline — not as a new infection. If both read negative, any future positive can be taken seriously as a real change.

This is also why the second test is placed one to three weeks after the first: long enough for boosting to appear, short enough that a genuine new infection in between is very unlikely.

Two timing rules matter. A reading outside the 48–72 hour window can't be used — a missed reading means that test is placed again, which is the most common way the process stretches past three weeks. And if you have had a documented skin test within the past 12 months, most programs count it as the first step and place only one more, so bring the record if you have it.

Live-virus vaccines (MMR, varicella, yellow fever) can blunt the skin-test reaction, so CDC guidance is to place the skin test either the same day as the vaccine or at least four weeks afterward — worth knowing if you are also catching up on titers or vaccines for the same program.

Only the firm, raised induration counts — not redness. The reader measures its width across the forearm in millimeters, and whether that number is "positive" depends on your risk category, which is why a trained reader interprets it rather than a ruler alone:

• 5 mm or more is positive for people with HIV, recent close contacts of someone with TB disease, people with fibrotic changes on a chest X-ray consistent with prior TB, organ-transplant recipients, and others who are significantly immunosuppressed (for example, the equivalent of 15 mg or more of prednisone daily for a month or longer).
• 10 mm or more is positive for people who arrived within the past five years from countries where TB is common, people who inject drugs, residents and employees of high-risk congregate settings (hospitals, nursing homes, correctional facilities, homeless shelters), mycobacteriology lab staff, people with medical conditions that raise the risk of TB disease (diabetes, chronic kidney disease, silicosis, some cancers, low body weight, prior gastrectomy or bypass), and children under 5 or children exposed to high-risk adults.
• 15 mm or more is positive for anyone, including people with no known risk factors.

For a second-step test, a positive reading is interpreted as a boosted reaction to an old infection or to BCG, not as a new infection — but it is still a positive result, and it leads to the same next step: an evaluation. A positive result means your immune system has responded to TB proteins, which is evidence you've been infected with TB bacteria at some point. It does not tell you whether that infection is latent (dormant, not contagious) or active TB disease. These are different conditions with different treatments, and no skin test or blood test can tell them apart on its own. The next step is a review of your symptoms and history plus a chest X-ray with a clinician, an urgent care, or your county health department.

A negative baseline means TB infection is unlikely, but doesn't completely rule it out — particularly if you have symptoms or a weakened immune system — and it can take 8 to 10 weeks after an exposure for a skin or blood test to turn positive. If you were recently exposed, a negative result should be repeated 8 to 10 weeks after your last exposure.

CDC's 2019 recommendations for health care personnel allow the baseline to be established with either a two-step skin test or a single TB blood test (an IGRA such as QuantiFERON-TB Gold Plus). Because the blood test measures an immune response in the lab rather than through a reaction on the skin, there is no boosting phenomenon to control for — one draw, one result, one visit instead of four.

The blood test has two further advantages for the people most often sent for a two-step: it is not affected by childhood BCG vaccination, which causes many of the false-positive and boosted skin-test reactions in staff and students born outside the United States, and it does not depend on returning inside a 48–72 hour window. Most hospitals, nursing programs and long-term care employers now accept it for the baseline; a growing number specify it.

There are still programs that require the skin test by name — some correctional and long-term care facilities, some state licensing rules, and any form that says PPD, Mantoux or two-step without an IGRA option. If your form names the skin test, check with whoever is requiring it before ordering a blood test; some programs will not accept a substitute. And if you have a documented prior positive skin test or prior TB treatment, CDC guidance is not to retest at all — what your program needs is proof of that result plus a chest X-ray or clinical evaluation, not another test.

If your program accepts an IGRA, the QuantiFERON-TB Gold Plus blood test is $91.99 through TestWell, drawn at any Quest or Labcorp with no appointment or doctor's visit, results in 3–5 business days. Programs that also want MMR, varicella and hepatitis B titers can get all four from the same draw with the Pre-Enrollment Health Panel. For where to go, see where to get a TB test near you; for the full comparison of the two methods, see TB blood test vs. skin test.

The baseline is meant to be done once. Since 2019, CDC no longer recommends routine annual TB testing for US health care personnel who have no known exposure and work where there is no ongoing transmission — the recommendation is a baseline test plus an individual risk assessment and symptom evaluation at hire, then annual TB education and testing only after an exposure or where transmission is documented. Many employers and clinical programs still require annual testing, and that is their call. If yours does, the same rule applies each year: a single skin test (no second step needed once a baseline exists) or a single blood test, and no retesting for anyone with a documented prior positive.